Cargando…

Agomelatine: A novel melatonergic antidepressant

Detalles Bibliográficos
Autor principal:	Manikandan, S
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2010
Materias:	Molecules of the Millennium
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3043343/ https://www.ncbi.nlm.nih.gov/pubmed/21350627 http://dx.doi.org/10.4103/0976-500X.72369

Ejemplares similares

Telavancin: A novel lipoglycopeptide antibiotic
por: Damodaran, S. E., et al.
Publicado: (2011)

Lorcaserin: A novel antiobesity drug
por: Brashier, Dick B. S., et al.
Publicado: (2014)

Lifitegrast: A novel drug for treatment of dry eye disease
por: Abidi, Afroz, et al.
Publicado: (2016)

Bedaquiline: A novel drug to combat multiple drug-resistant tuberculosis
por: Goel, Divya
Publicado: (2014)

Sofosbuvir: A novel treatment option for chronic hepatitis C infection
por: Bhatia, Harmeet Kaur, et al.
Publicado: (2014)

Ceftaroline fosamil: A novel anti-Methicillin-resistant Staphylococcus aureus cephalosporin
por: Girish, C., et al.
Publicado: (2011)

Belatacept: A worthy alternative to cyclosporine?
por: Melvin, George, et al.
Publicado: (2012)

Asenapine, a new sublingual atypical antipsychotic
por: Balaraman, R, et al.
Publicado: (2010)

Istaroxime: A rising star in acute heart failure
por: Aditya, Suruchi, et al.
Publicado: (2012)

Boceprevir: A new hope against hepatitis C virus
por: Brashier, Dick B. S., et al.
Publicado: (2012)

Delamanid: A new armor in combating drug-resistant tuberculosis
por: Xavier, Alphienes Stanley, et al.
Publicado: (2014)

Fingolimod (FTY720): First approved oral therapy for multiple sclerosis
por: Sharma, Sushil, et al.
Publicado: (2011)

Belimumab: First targeted biological treatment for systemic lupus erythematosus
por: Dubey, Ashok K., et al.
Publicado: (2011)

Ticagrelor: An emerging oral antiplatelet agent
por: Juneja, Shivani, et al.
Publicado: (2013)

Fospropofol
por: Mahajan, Bharti, et al.
Publicado: (2012)

Macitentan: An important addition to the treatment of pulmonary arterial hypertension
por: Khadka, Anjan, et al.
Publicado: (2015)

Naloxegol: First oral peripherally acting mu opioid receptor antagonists for opioid-induced constipation
por: Anantharamu, Tejus, et al.
Publicado: (2015)

Suvorexant: The first orexin receptor antagonist to treat insomnia
por: Dubey, Ashok K., et al.
Publicado: (2015)

An upcoming drug for onychomycosis: Tavaborole
por: Sharma, Neha, et al.
Publicado: (2015)

Proprotein convertase subtilisin/kexin type 9 enzyme inhibitors: An emerging new therapeutic option for the treatment of dyslipidemia
por: Mazhar, Faizan, et al.
Publicado: (2016)

A Systematic, Updated Review on the Antidepressant Agomelatine Focusing on its Melatonergic Modulation
por: Fornaro, Michele, et al.
Publicado: (2010)

The Melatonergic System in Mood and Anxiety Disorders and the Role of Agomelatine: Implications for Clinical Practice
por: De Berardis, Domenico, et al.
Publicado: (2013)

Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults
por: Howland, Robert H
Publicado: (2009)

The Millennium Project: the positive health implications of improved environmental sustainability
por: Melnick, Don J, et al.
Publicado: (2005)

Disease Emergence and Health Transitions in the Last Millennium
por: Donaldson, Liam
Publicado: (2000)

Will Medicine Be Revolutionised by Genomics?
por: Harris, Rodney
Publicado: (2000)

God, Mammon and the Physician: Medicine in England before the College
por: Rawcliffe, Carole
Publicado: (2000)

Changing Concepts of Health and Disease during the 20th Century
por: Booth, Christopher C
Publicado: (2000)

Imaging in Medicine through the 20th Century
por: Du Boulay, George
Publicado: (2000)

Acute toxicity and genotoxicity studies on new melatonergic antidepressant GW117
por: Gao, Mei, et al.
Publicado: (2023)

Melatonergic drugs in development
por: Carocci, Alessia, et al.
Publicado: (2014)

Potentiation of Antidepressant Effects of Agomelatine and Bupropion by Hesperidin in Mice
por: Nadar, Jegan Sakthivel, et al.
Publicado: (2018)

Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies
por: Taylor, David, et al.
Publicado: (2014)

Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies
Publicado: (2014)

The emergence of new antidepressants for clinical use: Agomelatine paradox versus other novel agents
por: Fasipe, Olumuyiwa John
Publicado: (2019)

Melatonin and melatonergic drugs in sleep disorders
por: Kim, Hyung Ki, et al.
Publicado: (2022)

Blockade of stress-induced increase of glutamate release in the rat prefrontal/frontal cortex by agomelatine involves synergy between melatonergic and 5-HT(2C )receptor-dependent pathways
por: Tardito, Daniela, et al.
Publicado: (2010)

Electroretinographic modifications induced by agomelatine: a novel avenue to the understanding of the claimed antidepressant effect of the drug?
por: Fornaro, Michele, et al.
Publicado: (2014)

Molecules for the millennium: how will they look? New drug discovery year 2000
por: Sausville, E A, et al.
Publicado: (2000)

JP Howard Fee MD, PhD, FFARCSI Introduction of The WFK Morrow Lecture
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_qqikfko7l3jvsod6ivlp44mho1